ACE Inhibitors Market Analysis, Revenue Share, Company Profiles, Launches, & Forecast Till 2027

 


According to MRFR analysis, ACE Inhibitors Market is expected to register a CAGR of 3.10% during the forecast period and is likely to be valued at USD 7682.8 Million.

The growth of the global ACE inhibitors market is determined by numerous factors such as rising adoption of ACE inhibitors for the treatment of cardiovascular complications and diabetic neuropathy, rising cases of cardiovascular disorders such as hypertension, and surge in demand for less expensive drugs. For instance, according to the data published by the World Health Organization (WHO) in 2017, the global prevalence rate of raised blood pressure in adults aged more than 18 was estimated to be 22.1% in 2017. However, ace inhibitors side effects associated with the treatment and high costs of treatment are likely to hamper the growth of the global ACE inhibitors market during the forecast period. 

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Americas has been segmented into North America and Latin America, with the North American market being divided into the US and Canada. The Americas is projected to hold the largest market share owing to the growing prevalence of hypertension and cardiovascular disorders.

The European ACE inhibitors market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The ACE inhibitors market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The presence of a huge population base, increasing awareness about cardiovascular disorders, and rising disposable income are the key factors responsible for the fastest growth of the market in Asia-Pacific. The ACE inhibitors market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global ACE Inhibitors Market has been segmented based on Product, Application, Dosage Form, and Distribution Channel.

The market, based on product, has been divided into lisinopril, ramipril, enalapril, benazepril, fosinopril, captopril, moexipril, and others. The lisinopril is likely to hold the maximum market share in the global ACE inhibitors market owing to the growing adoption of lisinopril in the management of cardiovascular complications and diabetic neuropathy.

The global ACE inhibitors market based on the application has been segregated into heart failure, hypertension, diabetes, heart attack, chronic kidney disease, and others. The hypertension segment is expected to hold a larger share of the market share owing to the rising cases of hypertension and the adoption of ACE inhibitors.

The ace inhibitors dosage form segment of the market is divided into oral tablets and oral solution. Capoten, Vasotec, Prinivil, Zestril, Lotensin, Monopril, and Altace are some well-known and widely used oral tablets.

Based on distribution channel, the global ACE inhibitors market has been segmented into retail pharmacy, hospital pharmacy, e-commerce websites and online drug stores, and others. Retail pharmacy holds maximum market share during the forecast period.

Key Players

Some of the Key Players in the Global ACE Inhibitors Market are Bristol-Myers Squibb Company (US), Par Pharmaceutical Companies, Inc. (US), UCB, Inc. (Belgium), Pfizer, Inc.(US), AbbVie Inc.(US), AstraZeneca (UK), Bausch Health Companies Inc.(Canada), Novartis AG (Switzerland), Merck & Co., Inc.(US), Teva Pharmaceutical Industries Ltd.(Israel), Silvergate Pharmaceuticals, Inc. (US), and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

 

Comments

Post a Comment

Popular posts from this blog

Doxorubicin Market Size, Revenue Analysis, Industry Outlook, Forecast Till 2030

Image
Doxorubicin is a type of chemotherapy medicine called an anthracycline. It is used to reduce or diminish the growth of cancer cells by blocking an enzyme called topo isomerase. Factors that are propelling the growth of the  doxorubicin market  are surge in geriatric population, rising prevalence of different types of cancer, increasing awareness for cancer treatment. According to the International Federation of Pharmaceutical Manufacturers & Associations, global pharmaceutical industry has spent more than USD 149.8 billion on pharmaceutical Research and development activities. The various side effects, cost containment policies by various governments, stringent regulatory environment for product approval, are likely to hinder market growth during the forecast period. Regional Analysis The American market is expected to dominate the global doxorubicin market during the forecast period due to the presence of major manufacturers, increase in number of cancer cases, awareness ...
Read more

Chromatography Software Market Size, Revenue Analysis, Industry Outlook, Forecast Till 2030

Image
According to MRFR analysis, the global  Chromatography Software Market  is expected to register a CAGR of ~8.1% from 2022 to 2030 and hold a value of USD 15,330 million by 2030. Chromatography software is the gadget that allows chromatography-based analysis. This software system organizes and manages data from chromatography instruments, records and processes it, and generates chromatograms and reports. Data processing, instrument control, and database management are automated using this chromatography data software. Chromatography informatics solutions are available in various formats, from integrated to automated independent software platforms. These tools are employed in multiple sectors, including materials science, drug development, and forensics. The growing demand for chromatography applications in different fields, surge in the utilization of chromatography techniques in R&D activities across various industries such as the pharmaceutical industry and increasing tec...
Read more

Orthokeratology Lens Market Revenue Trends, Company Profiles, Revenue Share Analysis Till 2030

Image
The   Orthokeratology Lens Market   is expected to reach USD 3,900.8 Million by 2030 at 7.8% CAGR during the forecast period 2022-2030. Orthokeratology is also known as ortho-k, corneal refractive therapy (CRT), and overnight vision correction therapy. In the orthokeratology therapy, rigid gas permeable contact lenses are worn overnight that reshapes the curvature of the cornea to improve object visibility. The use of ortho-k lenses eliminates the need for daytime contact lenses or glasses and improves vision. The increasing advancements in the field of ophthalmology over the past couple of decades, low cost compared to laser-assisted in situ keratomileuses (LASIK) treatment is anticipated to drive the market growth. However, the risk associated with orthokeratology and availability of alternative treatment methods is likely to hamper the market growth. Request Free Sample Copy at:  https://www.marketresearchfuture.com/sample_request/8218 Segment Analysis The global ortho...
Read more